EOS imaging Reports Half-Year 2019 Revenues
Summary
EOS imaging (Paris:EOSI) (Euronext, FR0011191766 – EOSI) a leader in 2D/3D orthopedic medical imaging and software solutions for 3D anatomical modeling and surgical planning today announces preliminary consolidated revenues for the half year ending June 30, 2019. Equipment orders are reported to provide advanced visibility and comparability on commercial performance vs. prior years. The number of equipment orders is in line with last year with positive trends in EMEA and in NAM, offsetting a planned decrease in APAC compared to a high basis in 2018. With a primary focus on hips, knees, and spine, EOS imaging is targeting a $2 billion annual market opportunity. EOS imaging has been chosen to be included in the new EnterNext© PEA-PME 150 index, composed of 150 French companies and listed on Euronext and Alternext markets in Paris.